Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. November 2015 07:00 ET | Quelle: Albireo Limited

Albireo to Present A4250 Clinical Data at the 2015 AASLD Annual Meeting

GOTHENBURG, Sweden and London, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a clinical-stage biopharmaceutical company developing through its operating subsidiary novel bile acid modulators to...
10. November 2015 07:00 ET | Quelle: Albireo Limited

Albireo Announces the Initiation in Japan of a Phase 3 Clinical Trial of Elobixibat in Chronic Constipation by Ajinomoto Pharmaceuticals

GOTHENBURG, Sweden and LONDON, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a clinical-stage biopharmaceutical company developing through its operating subsidiary novel bile acid modulators to...
23. September 2015 07:30 ET | Quelle: Albireo Limited

Albireo Appoints Ron Cooper, Former President of Europe at Bristol-Myers Squibb, as Chief Executive Officer

BOSTON, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a privately held company focused through its operating subsidiary on the development of bile acid modulators to treat orphan pediatric and...